High Serum Cholesteryl Ester Transfer Rates and Small High-Density Lipoproteins Are Associated With Young Age in Patients With Acute Myocardial Infarction

Journal of the American College of Cardiology

Volumn 50, Issue 20, 2007, Pages 1948-1955

  Zeller, Marianne ^a   Masson, David ^b,d   Farnier, Michel ^c   Lorgis, Luc ^d   Deckert, Valérie ^b   Pais de Barros, Jean Paul ^b   Desrumaux, Catherine ^b   Sicard, Pierre ^a   Grober, Jacques ^b   Blache, Denis ^b   Gambert, Philippe ^b,d   Rochette, Luc ^a   Cottin, Yves ^d   Lagrost, Laurent ^b  

^a IFR Sante STIC   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Point Medical   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SMOKING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 35748931756     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.06.052     Document Type: Article

References (40)

1. Inazu A., Brown M.L., Hesler C.B., et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323 (1990) 1234-1238
2. Brousseau M.E., Schaefer E.J., Wolfe M.L., et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL-cholesterol. N Engl J Med 350 (2004) 1505-1515
3. Tall A.R., Yvan-Charvet L., and Wang N. The failure of torcetrapib: was it the molecule or the mechanism?. Arterioscler Thromb Vasc Biol 27 (2007) 257-260
4. Zhuang Y., Wang J., Qiang H., et al. Serum cholesteryl ester transfer protein concentrations in healthy Chinese subjects and cardio-cerebrovascular disease patients. Clin Chim Acta 305 (2001) 19-25
5. Kamigaki A.S., Siscovick D.S., Schwartz S.M., et al. Low density lipoprotein particle size and risk of early-onset myocardial infarction in women. Am J Epidemiol 153 (2001) 939-945
6. Packard C.J. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 17 (2006) 412-417
7. Curb J.D., Abbott R.D., Rodriguez B.L., et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 45 (2004) 948-953
8. Boekholdt S.M., Kuivenhoven J.A., Wareham N.J., et al. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation Into Cancer and Nutrition)-Norfolk population study. Circulation 110 (2004) 1418-1423
9. de Vries R., Perton F.G., Dallinga-Thie G.M., et al. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes 54 (2005) 3554-3559
10. Klerkx A.H., de Grooth G.J., Zwinderman A.H., Jukema J.W., Kuivenhoven J.A., and Kastelein J.J. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS). Eur J Clin Invest 34 (2004) 21-28
11. de Grooth G.J., Smilde T.J., Van Wissen S., et al. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. Atherosclerosis 173 (2004) 261-267
12. Nissen S.E., Tardif J.C., Nicholls S.J., et al., ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 356 (2007) 1304-1316
13. Tall A.R. CETP inhibitors to increase HDL-cholesterol levels. N Engl J Med 356 (2007) 1364-1366
14. Kastelein J.J.P., van Leuven S.I., Burgess L., et al., RADIANCE 1 Investigators. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 356 (2007) 1620-1630
15. Rosenson R.S. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 22 (1993) 933-940
16. Ryder R.E., Hayes T.M., Mulligan I.P., Kingswood J.C., Williams S., and Owens D.R. How soon after myocardial infarction should plasma lipid values be assessed?. Br Med J (Clin Res Ed) 289 (1984) 1651-1653
17. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
18. Guyard-Dangremont V., Lagrost L., Gambert P., and Lallemant C. Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin Chim Acta 231 (1994) 147-160
19. Braschi S., Masson D., Rostoker G., et al. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol 17 (1997) 2559-2567
20. Braschi S., Lagrost L., Florentin E., et al. Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler Thromb Vasc Biol 16 (1996) 441-449
21. Dedecjus M., Masson D., Gautier T., et al. Low cholesteryl ester transfer protein (CETP) concentration but normal CETP activity in serum from patients with short-term hypothyroidism. Lack of relationship to lipoprotein abnormalities. Clin Endocrinol 58 (2003) 581-588
22. Lagrost L., Athias A., Herbeth B., et al. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J Biol Chem 271 (1996) 19058-19065
23. Kreisberg R.A., and Kasim S. Cholesterol metabolism and aging. Am J Med 82 (1987) 54-60
24. Lemieux I., Pascot A., Tchernof A., et al. Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men. Metabolism 48 (1999) 1322-1327
25. McNamara J.R., Campos H., Ordovas J.M., Peterson J., Wilson P.W., and Schaefer E.J. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 7 (1987) 483-490
26. Rizzo M., Barbagallo C.M., Severino M., et al. Low-density-lipoprotein peak particle size in a Mediterranean population. Eur J Clin Invest 33 (2003) 126-133
27. Hamilton M.T., Areigat E., Hamilton D.G., and Bey L. Plasma triglyceride metabolism in humans and rats during aging and physical inactivity. Int J Sport Nutr Exerc Metab 11 (2001) S97-S104
28. Wilson P.W., Anderson K.M., Harris T., Kannel W.B., and Castelli W.P. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 49 (1994) M252-M257
29. Chen L., Chester M., and Kaski J.C. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 108 (1995) 364-369
30. Boekholdt S.M., Sacks F.M., Jukema J.W., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111 (2005) 278-287
31. Kuivenhoven J.A., Jukema J.W., Zwinderman A.H., et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 338 (1998) 86-93
32. Marschang P., Sandhofer A., Ritsch A., Fiser I., Kvas E., and Patsch J.R. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin. J Intern Med 260 (2006) 151-159
33. Clay M.A., Newnham H.H., Forte T.M., and Barter P.I. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1124 (1992) 52-58
34. Lagrost L., Gambert P., and Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb Vasc Biol 14 (1994) 1327-1336
35. Packard C.J., and Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17 (1997) 3542-3556
36. Marsh J.B., Welty F.K., and Schaefer E.J. Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans. Curr Opin Lipidol 11 (2000) 261-266
37. Marsh J.B., Welty F.K., Lichtenstein A.H., Lamon-Fava S., and Schaefer E.J. Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. Atherosclerosis 162 (2002) 227-244
38. Zak Z., Lagrost L., Gautier T., et al. Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL. J Lipid Res 43 (2002) 2164-2171
39. Steg P.G., Goldberg R.J., Gore J.M., et al., GRACE Investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90 (2002) 358-363
40. Wu A.H., Parsons L., Every N.R., Bates E.R., and Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 40 (2002) 1389-1394